» Articles » PMID: 26713677

Lipid Droplets, Lipophagy, and Beyond

Overview
Specialties Biochemistry
Biophysics
Date 2015 Dec 30
PMID 26713677
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Lipids are essential components for life. Their various structural and physical properties influence diverse cellular processes and, thereby, human health. Lipids are not genetically encoded but are synthesized and modified by complex metabolic pathways, supplying energy, membranes, signaling molecules, and hormones to affect growth, physiology, and response to environmental insults. Lipid homeostasis is crucial, such that excess fatty acids (FAs) can be harmful to cells. To prevent such lipotoxicity, cells convert excess FAs into neutral lipids for storage in organelles called lipid droplets (LDs). These organelles do not simply manage lipid storage and metabolism but also are involved in protein quality management, pathogenesis, immune responses, and, potentially, neurodegeneration. In recent years, a major trend in LD biology has centered around the physiology of lipid mobilization via lipophagy of fat stored within LDs. This review summarizes key findings in LD biology and lipophagy, offering novel insights into this rapidly growing field. This article is part of a Special Issue entitled: The cellular lipid landscape edited by Tim P. Levine and Anant K. Menon.

Citing Articles

Targeting membrane contact sites to mediate lipid dynamics: innovative cancer therapies.

Wang J, Wang M, Zeng X, Li Y, Lei L, Chen C Cell Commun Signal. 2025; 23(1):89.

PMID: 39955542 PMC: 11830217. DOI: 10.1186/s12964-025-02089-z.


Silybin A from reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids.

Koeberle S, Thurmer M, Su F, Werner M, Grander J, Hofer L Theranostics. 2025; 15(5):2006-2034.

PMID: 39897559 PMC: 11780512. DOI: 10.7150/thno.99562.


From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease.

Xu W, Zhu Y, Wang S, Liu J, Li H Antioxidants (Basel). 2025; 13(12.

PMID: 39765868 PMC: 11727289. DOI: 10.3390/antiox13121540.


Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy.

Zhang H, Li Y, Huang J, Shen L, Xiong Y Acta Pharm Sin B. 2024; 14(11):4717-4737.

PMID: 39664426 PMC: 11628863. DOI: 10.1016/j.apsb.2024.07.021.


A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells.

Pang M, Yu L, Li X, Lu C, Xiao C, Liu Y Cell Death Dis. 2024; 15(8):562.

PMID: 39098929 PMC: 11298533. DOI: 10.1038/s41419-024-06956-4.